Clinical Benefits of a Bloodless Medicine & Surgery Program
Bloodless Medicine and Surgery Programs (BMSP) aim to minimize or eliminate the need for blood transfusions through the use of alternative techniques and treatments. There are a number of risks associated with blood transfusions, including both infectious and non-infectious risks.
Some of the non-infectious risks associated with blood transfusions include:
Mistransfusion: Human error can occur during the transfusion process, leading to the wrong blood type being administered to the patient
ABO/Rh-incompatibility: If a patient receives blood that is not compatible with their blood type, it can lead to an immune response that can cause serious complications.
Cardiopulmonary toxicity: Blood transfusions can put a strain on the heart and lungs, especially in patients with pre-existing cardiac or pulmonary conditions.
Transfusion-related acute lung injury (TRALI): TRALI is a rare but serious complication that can occur following a blood transfusion and can lead to respiratory failure.
Transfusion-related immunomodulation: Blood transfusions can suppress the patient's immune system, increasing their risk of infection and delaying recovery.
Research has shown that patients who avoid blood transfusions can experience faster recovery times, fewer infections, and shorter hospital stays. By implementing a BMSP, hospitals can reduce the risks associated with blood transfusions and provide safer and more effective medical care to their patients.